Atlas Trials

Hangzhou Sciwind Biosciences Co., Ltd.

12 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Hangzhou Sciwind Biosciences Co., Ltd.

RecordFirmDate
A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA) (NCT07734311)Hangzhou Sciwind Biosciences Co., Ltd.2026-07-31
A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy (NCT07434050)Hangzhou Sciwind Biosciences Co., Ltd.2026-03-02
A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity (NCT07243171)Hangzhou Sciwind Biosciences Co., Ltd.2025-11-18
A Study of XW003 Injection in Chinese Adolescents With Obesity (NCT07143227)Hangzhou Sciwind Biosciences Co., Ltd.2025-08-25
A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH) (NCT07073417)Hangzhou Sciwind Biosciences Co., Ltd.2025-07-28
A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin (NCT06335134)Hangzhou Sciwind Biosciences Co., Ltd.2023-07-14
A Study To Evaluate the Safety of XW001 Inhalation in Children With RSV (NCT05779995)Hangzhou Sciwind Biosciences Co., Ltd.2023-04-20
A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM (NCT05680129)Hangzhou Sciwind Biosciences Co., Ltd.2023-01-10
A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients (NCT05680155)Hangzhou Sciwind Biosciences Co., Ltd.2022-12-29
A Study of XW001 in Healthy Adult Subjects (NCT05642403)Hangzhou Sciwind Biosciences Co., Ltd.2021-01-03

Track Hangzhou Sciwind Biosciences Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.